Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2899 Using Long-Acting Somatostatin Analogue as Adjuvant Therapy for Post Resection Grade 2 Pancreatic Neuroendocrine Tumor: Interim Results from an Ongoing Multicenter Real-World Study in China

Introduction: Surgery was the preferred treatment in patients with resectable pancreatic neuroendocrine tumor (pNET), but recurrent lesion relapsed frequently within a short time. It was controversial whether patients with pNET need adjuvant therapy after surgery.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Shi X

Authors: Shi X, Xu X, Zhang Y, Gao S, Li B,

Keywords: somatostatin analogue, adjuvant therapy, pancreatic neuroendocrine tumor,

#2175 A Retrospective Analysis of 344 Cases with Neuroendocrine Neoplasms

Introduction: Ki-67 is a nuclear protein that is strictly associated with cellular proliferation,acting as a cellular marker for proliferation in clinical practice to determine the degree to which the tumor cells are duplicating. Ki-67 index strongly ties to the prognosis and provides guiding significance to clinical decisions.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Liu Z, Zhao H, Wu Y, Jiang L, Shi S,

Keywords: ki-67 index, neuroendocrine neoplasm, prognosis,

#1659 Multicenter Analysis of the Clinicopathological Characteristics and Prognosis of Colonic Neuroendocrine Neoplasms

Introduction: Neuroendocrine neoplasms (NEN) arising from colon is rare. Few studies investigate the clinicopathological features and prognosis of colonic NEN.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Chen L

Authors: Chen L, Wang W, Feng X, Zeng Y, Jin K,

Keywords: colon, neuroendocrine neoplasms, clinicopathological features, prognosis,

#1611 A Study of S1/Temozolomide (STEM) Regimen in Patients with Metastatic Neuroendocrine Tumors

Introduction: Both single agent Capecitabine alone or Capecitabine in combination with Temozolomide have activity against neuroendocrine tumors (NETs), however, the role of S-1 in NETs is still unknown.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yihebali C, Jiuda Z, Yufeng W, Ba B, Liming J,

Keywords: Neuroendocrine tumors, Chemotherapy, S1,Temozolomide,

#1583 The Clinical Pathological Characteristics and Prognostic Factors of Rectal Neuroendocrine Tumors- A Retrospective Analysis Based on Multi Center Data

Introduction: The pathological characteristics and prognosis factors of rectum neuroendocrine tumor still have a lot of uncertainty.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: gengzhou w

Authors: Gengzhou W, Wei W, Xingyu F,

Keywords: rectal, neuroendocrine neoplasms, prognosis, grade, size, stage,